A Phase Ii Multicenter, Open Label, Non-Randomized Study Of Neoadjuvant And Adjuvant Treatment With Iph5201 And Durvalumab In Patients With Resectable, Early-Stage (Ii To Iiia) Non-Small Cell Lung Cancer (Matisse)
Durvalumab;IPH-5201
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase Ii Multicenter, Open Label, Non-Randomized Study Of Neoadjuvant And Adjuvant Treatment With Iph5201 And Durvalumab In Patients With Resectable, Early-Stage (Ii To Iiia) Non-Small Cell Lung Cancer (Matisse) ### Output: Durvalumab;IPH-5201